A Growing Population of Older Adults with Sickle Cell Disease

Overview

Journal Clin Geriatr Med

Specialty Geriatrics

Date 2019 Jun 25

PMID 31230736

Citations 5

Authors

Arun S Shet

Swee Lay Thein

Affiliations

Soon will be listed here.

Abstract

In countries with organized access to health care, survival of patients with sickle cell disease (SCD) has greatly improved, shifting the burden of care from a pediatrician to an internal medicine physician. As a consequence, cumulative disease complications related to chronic vasculopathy are becoming more apparent, adding to organ dysfunction from physiologic aging. The time has come for us to reevaluate the approach to managing the older adult with SCD by putting a greater emphasis on geriatric conditions while proactively considering curative options once previously offered only to younger patients, with comprehensive annual assessments and joint clinics with relevant specialists.

Citing Articles

Clinical Insights into Sickle Cell Disease: A Comprehensive Multicenter Retrospective Analysis of Clinical Characteristics and Outcomes Across Different Age Groups.

Almarghalani D, Alotaibi R, Alzlami T, Alhumaidi O, Alharthi N, Alboqami F J Clin Med. 2024; 13(23).

PMID: 39685683 PMC: 11641892. DOI: 10.3390/jcm13237224.

Pulmonary Function after Nonmyeloablative Hematopoietic Cell Transplant for Sickle Cell Disease.

Ruhl A, Shalhoub R, Jeffries N, Limerick E, Leonard A, Barochia A Ann Am Thorac Soc. 2024; 21(10):1398-1406.

PMID: 39189784 PMC: 11451896. DOI: 10.1513/AnnalsATS.202309-771OC.

Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy.

Graziadei G, De Franceschi L, Sainati L, Venturelli D, Masera N, Bonomo P Front Med (Lausanne). 2022; 9:832154.

PMID: 35372393 PMC: 8967327. DOI: 10.3389/fmed.2022.832154.

COVID-19 and sickle cell disease.

Menapace L, Thein S Haematologica. 2020; 105(11):2501-2504.

PMID: 33131239 PMC: 7604559. DOI: 10.3324/haematol.2020.255398.

Time to apply a social determinants of health lens to addressing sickle cell disorders in sub-Saharan Africa.

Berghs M, Ola B, Cronin de Chavez A, Ebenso B BMJ Glob Health. 2020; 5(7).

PMID: 32723757 PMC: 7388876. DOI: 10.1136/bmjgh-2020-002601.

References

Esrick E, Bauer D . Genetic therapies for sickle cell disease. Semin Hematol. 2018; 55(2):76-86. DOI: 10.1053/j.seminhematol.2018.04.014. View

Ballas S, Kesen M, Goldberg M, Lutty G, Dampier C, Osunkwo I . Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal. 2012; 2012:949535. PMC: 3415156. DOI: 10.1100/2012/949535. View

Steinberg M, Mccarthy W, Castro O, Ballas S, Armstrong F, Smith W . The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. Am J Hematol. 2010; 85(6):403-8. PMC: 2879711. DOI: 10.1002/ajh.21699. View

Birkeland P, Gardner K, Kesse-Adu R, Davies J, Lauritsen J, Poulsen F . Intracranial Aneurysms in Sickle-Cell Disease Are Associated With the Hemoglobin SS Genotype But Not With Moyamoya Syndrome. Stroke. 2016; 47(7):1710-3. DOI: 10.1161/STROKEAHA.116.012664. View

CHARACHE S, Terrin M, Moore R, Dover G, Barton F, Eckert S . Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995; 332(20):1317-22. DOI: 10.1056/NEJM199505183322001. View

Mathew R, Bafiq R, Ramu J, Pearce E, Richardson M, Drasar E . Spectral domain optical coherence tomography in patients with sickle cell disease. Br J Ophthalmol. 2015; 99(7):967-72. DOI: 10.1136/bjophthalmol-2014-305532. View

Yawn B, Buchanan G, Afenyi-Annan A, Ballas S, Hassell K, James A . Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014; 312(10):1033-48. DOI: 10.1001/jama.2014.10517. View

Gladwin M, Sachdev V, Jison M, Shizukuda Y, Plehn J, Minter K . Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004; 350(9):886-95. DOI: 10.1056/NEJMoa035477. View

Vichinsky E, Neumayr L, Earles A, Williams R, Lennette E, Dean D . Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000; 342(25):1855-65. DOI: 10.1056/NEJM200006223422502. View

10.

Jack C, Howard J, Aziz E, Kesse-Adu R, Bankes M . Cementless total hip replacements in sickle cell disease. Hip Int. 2015; 26(2):186-92. DOI: 10.5301/hipint.5000317. View

11.

Telfer P, Coen P, Chakravorty S, Wilkey O, Evans J, Newell H . Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica. 2007; 92(7):905-12. DOI: 10.3324/haematol.10937. View

12.

Smith W, McClish D, Dahman B, Levenson J, Aisiku I, Citero V . Daily home opioid use in adults with sickle cell disease: The PiSCES project. J Opioid Manag. 2015; 11(3):243-53. DOI: 10.5055/jom.2015.0273. View

13.

Powars D, Chan L, Hiti A, Ramicone E, Johnson C . Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore). 2005; 84(6):363-376. DOI: 10.1097/01.md.0000189089.45003.52. View

14.

Kassim A, Pruthi S, Day M, Rodeghier M, Gindville M, Brodsky M . Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia. Blood. 2016; 127(16):2038-40. DOI: 10.1182/blood-2016-01-694562. View

15.

Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G . A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med. 2011; 365(1):44-53. DOI: 10.1056/NEJMoa1005565. View

16.

Vidler J, Gardner K, Amenyah K, Mijovic A, Thein S . Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience. Br J Haematol. 2015; 169(5):746-53. DOI: 10.1111/bjh.13339. View

17.

Walters M, De Castro L, Sullivan K, Krishnamurti L, Kamani N, Bredeson C . Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease. Biol Blood Marrow Transplant. 2015; 22(2):207-211. PMC: 5031360. DOI: 10.1016/j.bbmt.2015.10.017. View

18.

Downes S, Hambleton I, Chuang E, Lois N, Serjeant G, Bird A . Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology. 2005; 112(11):1869-75. DOI: 10.1016/j.ophtha.2005.05.026. View

19.

McGann P, Hernandez A, Ware R . Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research. Blood. 2016; 129(2):155-161. PMC: 5234214. DOI: 10.1182/blood-2016-09-702324. View

20.

Thein S, Tisdale J . Sickle cell disease-Unanswered questions and future directions in therapy. Semin Hematol. 2018; 55(2):51-52. PMC: 11424032. DOI: 10.1053/j.seminhematol.2018.05.010. View